You J - Search Results

1

Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics.

Wang S, Xia Z, You J, Gu X, Meng F, Chen P, Tang W, Bao H, Zhang J, Wu X, Shao Y, Wang J, Zuo X, Xu L, Yin R. Wang S, et al. Among authors: you j. Cancer Res Commun. 2023 May 30;3(5):933-942. doi: 10.1158/2767-9764.CRC-22-0363. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377889 Free PMC article.

2

Whole-Exome Sequencing Reveals the Genomic Features of the Micropapillary Component in Ground-Glass Opacities.

Meng F, Zhang Y, Wang S, Liu T, Sun M, Zhu H, Dong G, Xia Z, You J, Kong X, Wu J, Chen P, Yuan F, Yu X, Xu Y, Xu L, Yin R. Meng F, et al. Among authors: you j. Cancers (Basel). 2022 Aug 27;14(17):4165. doi: 10.3390/cancers14174165. Cancers (Basel). 2022. PMID: 36077702 Free PMC article.

3

[Correlation between Immune Microenvironment Features and EGFR Mutation Status  in Lung Adenocarcinoma].

Zhu H, Chen P, Dong G, Meng F, Xia Z, You J, Kong X, Wu J, Yuan F, Yu X, Sun Q, Ji J, Wang S, Liu T, Xu L. Zhu H, et al. Among authors: you j. Zhongguo Fei Ai Za Zhi. 2023 Mar 20;26(3):204-216. doi: 10.3779/j.issn.1009-3419.2023.101.07. Zhongguo Fei Ai Za Zhi. 2023. PMID: 37035883 Free PMC article. Chinese.

4

Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing.

Ma Z, Chen H, Xia Z, You J, Han C, Wang S, Xia W, Bai Y, Liu T, Xu L, Zhou G, Xu Y, Yin R. Ma Z, et al. Among authors: you j. J Exp Clin Cancer Res. 2023 Jul 17;42(1):169. doi: 10.1186/s13046-023-02723-z. J Exp Clin Cancer Res. 2023. PMID: 37461053 Free PMC article.

5

Correction: Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing.

Ma Z, Chen H, Xia Z, You J, Han C, Wang S, Xia W, Bai Y, Liu T, Xu L, Zhou G, Xu Y, Yin R. Ma Z, et al. Among authors: you j. J Exp Clin Cancer Res. 2023 Jul 25;42(1):180. doi: 10.1186/s13046-023-02771-5. J Exp Clin Cancer Res. 2023. PMID: 37488652 Free PMC article. No abstract available.

6

[Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities].

Xu Y, Sun Q, Wang S, Zhu H, Dong G, Meng F, Xia Z, You J, Kong X, Wu J, Chen P, Yuan F, Yu X, Ji J, Li Z, Zhu P, Sun Y, Liu T, Yin R, Xu L. Xu Y, et al. Among authors: you j. Zhongguo Fei Ai Za Zhi. 2024 Jan 2;26(12):889-900. doi: 10.3779/j.issn.1009-3419.2023.106.23. Epub 2023 Dec 28. Zhongguo Fei Ai Za Zhi. 2024. PMID: 38151328 Free PMC article. Chinese.

7

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non-small cell lung cancer.

Yang D, Cui J, Zhao J, You J, Yu R, Yu H, Jiang L, Li D, Xu B, Shi A. Yang D, et al. Among authors: you j. Thorac Cancer. 2020 Mar;11(3):754-761. doi: 10.1111/1759-7714.13335. Epub 2020 Feb 3. Thorac Cancer. 2020. PMID: 32012484 Free PMC article.

8

Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.

Zheng Y, Shi A, Wang W, Yu H, Yu R, Li D, Xu B, Ma H, You J, Zhao D, Jiang L, Geng J, Zhu G. Zheng Y, et al. Among authors: you j. Clin Lung Cancer. 2018 Jul;19(4):e399-e404. doi: 10.1016/j.cllc.2017.12.012. Epub 2018 Jan 4. Clin Lung Cancer. 2018. PMID: 29519614

9

[Application of Simultaneous Integrated Boost Intensity Modulated Radiotherapy in Locally Advanced Non-small Cell Lung Cancer].

You J, Yang D, Li D, Jiang L, Yu R, Yu H, Xu B, Wang W, Shi A. You J, et al. Zhongguo Fei Ai Za Zhi. 2019 Nov 20;22(11):696-701. doi: 10.3779/j.issn.1009-3419.2019.11.03. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31771738 Free PMC article. Chinese.

10

[A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy  Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].

You J, Yu H, Song M, Shi C, Wang X, Zheng Y, Yu R, Shi A, Zhu G. You J, et al. Zhongguo Fei Ai Za Zhi. 2017 Jan 20;20(1):28-34. doi: 10.3779/j.issn.1009-3419.2017.01.04. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28103970 Free PMC article. Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,377 results

Search Page